What Is Prior Authorization?

Prior authorization (PA) is a requirement imposed by most health insurance plans before they'll cover a GLP-1 medication. Think of it as the insurer asking your doctor to prove the medication is medically necessary before they agree to pay for it. Nearly every plan that covers GLP-1s requires this step, regardless of whether the medication is being prescribed for diabetes or weight management.

The process involves your healthcare provider submitting clinical documentation to the insurer, who then evaluates whether you meet their specific coverage criteria. This can take anywhere from 24 hours to several weeks, depending on the insurer and the completeness of the submission.

Why So Many PA Requests Get Denied

Many GLP-1 prior authorization denials happen not because the patient doesn't qualify, but because the submission was incomplete or didn't match the insurer's specific criteria language. Common reasons for denial include missing BMI documentation or BMI recorded outside the required timeframe (most plans require measurement within the past 3 to 6 months), failure to document qualifying comorbidities using the insurer's accepted diagnosis codes, incomplete step-therapy documentation showing prior weight-loss attempts, prescribing for an off-label indication, and submitting the PA for the wrong indication (weight management vs. diabetes).

Key insight: The indication matters enormously. Submitting a PA for Wegovy (weight management indication) follows different criteria than Ozempic (diabetes indication), even though both contain semaglutide. Your provider should match the PA to the specific FDA-approved indication and the insurer's formulary requirements.

What Insurers Look For

While every plan has its own specific criteria, the typical PA evaluation checks several categories. First, label match: does your diagnosis align with the FDA-approved indication for the specific medication? Second, BMI and comorbidity documentation: is your BMI at or above the threshold, and are qualifying conditions documented? Third, step therapy: have you tried other interventions first? Many plans require evidence of prior lifestyle modifications (diet, exercise) or previous medication trials. Fourth, quantity limits: plans often restrict dosing escalation speed and supply quantities.

Building a Strong First Submission

The single most important factor in first-pass approval is the completeness of the initial submission. Before your provider submits the PA, gather the following: a recent BMI measurement (ideally within 90 days) documented in your medical chart, lab results supporting any qualifying comorbidities (A1C for diabetes/prediabetes, lipid panel for dyslipidemia, blood pressure readings), documentation of previous weight-loss attempts (prior diet programs, exercise regimens, or medications tried), a current medication list, and any relevant specialist records (cardiology, endocrinology, sleep medicine).

Your provider should reference current clinical guidelines — such as the American Gastroenterological Association (AGA) or Endocrine Society obesity treatment guidelines — in their letter of medical necessity. Submissions that cite these guidelines have measurably higher approval rates.

The Step-Therapy Requirement

Many insurers require documentation that you've tried less expensive interventions before approving a GLP-1. This typically means evidence of a structured diet and exercise program (usually 3 to 6 months), and sometimes a trial of an older or less expensive medication such as metformin, naltrexone-bupropion (Contrave), or phentermine.

If you've previously attempted these interventions — even informally — your provider should document them explicitly. A note stating "patient reports multiple unsuccessful diet attempts over the past two years" is better than no documentation at all, but specific details (program names, durations, outcomes) strengthen the submission considerably.

Timeline and What to Expect

Standard PA processing typically takes 5 to 15 business days. Urgent or expedited requests (which your provider can submit if there's a clinical reason for faster processing) should be resolved within 24 to 72 hours. During this period, you should receive updates from either your provider's office or the insurer. If you haven't heard anything after two weeks, contact both your provider and the insurer to check the status.

Tips From Providers Who Get Approved Consistently

Experienced prescribers share several strategies that improve approval rates. They use the insurer's own PA form rather than a generic letter. They match the exact diagnosis codes and medication indications the plan requires. They include all supporting documentation in the initial submission rather than sending it piecemeal. They reference specific clinical guidelines by name. And they pre-verify the patient's formulary status and plan-specific criteria before prescribing, so they know exactly what the insurer is looking for before they submit.

Pro tip: Ask your provider's office to call the insurer's pharmacy benefits line before submitting the PA. A five-minute call can reveal the exact criteria, required documentation, and preferred forms — information that dramatically increases first-pass approval rates.

If You're Approved

Once approved, the PA is typically valid for 6 to 12 months, after which a re-authorization may be required. The re-authorization usually requires documentation of treatment progress (such as percentage of weight lost or A1C improvement). Stay on top of the expiration date — a lapse in PA can result in a gap in medication access.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. GLP-1 receptor agonists are prescription medications with potential side effects and contraindications. Compounded medications are not FDA-approved. Pricing, coverage, and program details are subject to change—verify directly with providers and insurers.